Pac Roots Cannabis Corp. (CSE: PACR) Employs Specialized Proprietary Cultivation Techniques, Seeks to Deliver on Higher-Quality Product Portfolio

  • Pac Roots Cannabis Corp. dedicated to supplying higher-quality cannabis product
  • PACR enters into strategic licensing agreement with Phenome One Corp, providing access to 350 meticulously-designed cultivars
  • Company has also employed number of proprietary cultivation techniques to ensure quality of end products, which has contributed to PACR’s stellar industry reputation

Since completing its RTO and being listed on the CSE in May of 2020, Pac Roots Cannabis Corp. (CSE: PACR) has established a strong reputation within the field of cannabis and hemp cultivation, leveraging upon the exceptional genetics of its specialized cultivars as well as an innovative proprietary cultivation technique to ensure the production of extremely high-quality strains. The company’s relentless focus on quality and cutting-edge agricultural methodology has earned it a growing reputation within the global legal cannabis industry—a burgeoning consumer sector expected to surge to an annual value of over $90 billion by 2027, according to a recent study carried out by Data Bridge Market Research (https://cnw.fm/WcxZU).

The enactment of a variety of new laws providing medical patients and recreational consumers with legal access to cannabis has led to a surge in demand for the plant, a need which has grown in-line with the explosive rise in retail demand for marijuana, edibles, and concentrate-based products. With the North American marijuana industry set to grow at a CAGR of 20% over the coming decade, cannabis cultivators have been increasingly hard-pressed to balance the need to ensure bountiful harvests while adhering to stringent quality criteria.

Pac Roots Cannabis Corp., however, has taken multiple measures to ensure the quality of its product. Through a strategic licensing agreement with Phenome One Corp (https://cnw.fm/fZNtD), Pac Roots has gained access to one of Canada’s largest live, genetic cannabis libraries with lab and field-tested, selectively bred seedlings which the company has employed to grow, breed and clone their own unique brands. The partnership has enabled Pac Roots to offer customers a remarkable portfolio of over 350 meticulously-designed cultivars, ranging from CBD-dominant plants with rare terpene profiles to plants with over 30% THC-content as well as West Coast outdoor, botrytis-resistant cultivars.

Through this alliance with Phenome One, Pac Roots has been able to both deliver rich THC and CBD cultivars with unique terpene profiles while simultaneously delivering upon industry-leading grams per watt (“GPW”) yields.

In addition to the company’s meticulous focus on high-quality cultivars, Pac Roots places great emphasis on optimizing the cultivation process by employing a series of unique and proprietary methods. Cannabis plants require varying levels of specific nutrients and soil additives at different stages of growth. These needs can change, depending on whether the plant is still in a vegetative growth phase or nearing its flowering stage.

Pac Roots has sought to address these requirements by custom-formulating nutrients from raw salts, enabling them to cater to the individual requirements of each specific cultivar. In contrast to most commercial growers currently employing commercially available additives, Pac Root’s meticulous focus on customizing the nutrients of each specific cultivar has allowed the company to maximize the CBD and THC profiles of each of its plants – ultimately translating into a higher-quality end product for the retail customers.

Another key issue that has constantly befallen cannabis cultivators is the potential for pests and disease factors, which, if left unchecked, could often have a devastating impact on biomass production yields. Pac Roots addresses these concerns through a two-fold approach, namely by picking the right soil or terroir in which to plant as well as by employing row compaction and specialized mowing techniques, allowing the company’s highly trained workforce to eliminate any potential sources of plant contamination at an early stage.

“It has been a busy for months since listing on the CSE in early May 2020,” said Pac Roots CEO Patrick Elliott. “We are proud to have a healthy crop and remain bullish on delivering a premium, high-yielding product to our customer.”

For more information, visit the company’s website at www.PacRoots.ca.

NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://cnw.fm/PACR

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

Archives

Select A Month

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722